UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.62-62, Article 62

2020

Volltextzugriff (PDF)

Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study

Liver cancer (Basel ), 2021-07, Vol.10 (4), p.296-308

2021

Volltextzugriff (PDF)

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer

BMC cancer, 2019-08, Vol.19 (1), p.791-10, Article 791

2019

Volltextzugriff (PDF)

Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression

Scientific reports, 2018-04, Vol.8 (1), p.6586-8, Article 6586

2018

Volltextzugriff (PDF)

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment

Hepatology international, 2022-10, Vol.16 (5), p.1199-1207

2022

Volltextzugriff (PDF)

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

Journal of cellular and molecular medicine, 2011-04, Vol.15 (4), p.825-836

2011

Volltextzugriff (PDF)

Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer

Cancer medicine (Malden, MA), 2024-01, Vol.13 (2), p.e6972-n/a

2024

Volltextzugriff (PDF)

Emerging role of microRNA-21 in cancer

Biomedical reports, 2016-10, Vol.5 (4), p.395-402

2016

Volltextzugriff (PDF)

The association between obesity and gynecological cancer

Gynecology and minimally invasive therapy, 2015-11, Vol.4 (4), p.102-105

Feng, Yin-Hsun

2015

Volltextzugriff (PDF)

Concurrent chemoradiotherapy in patients with non‐metastatic upper urinary tract urothelial carcinoma: Report from a single institution in Taiwan

International journal of urology, 2020-01, Vol.27 (1), p.83-84

2020

Volltextzugriff (PDF)

The impact of COVID-19 on cardio-oncology care in Taiwan

Journal of the Formosan Medical Association, 2022-04, Vol.121 (4), p.861-864

2022

Volltextzugriff (PDF)

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes

International journal of molecular sciences, 2020-02, Vol.21 (5), p.1672

2020

Volltextzugriff (PDF)

Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety

Journal of the Formosan Medical Association, 2022-12, Vol.121 (12), p.2430-2437

2022

Volltextzugriff (PDF)

Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study

BMC cancer, 2019-05, Vol.19 (1), p.461-11, Article 461

2019

Volltextzugriff (PDF)

Dignity and Related Factors in Patients with Cancer: A Cross-Sectional Study

Asian nursing research, 2023-02, Vol.17 (1), p.8-14

2023

Volltextzugriff (PDF)

Correlation of Insulin-Like Growth Factor 1 With Cognitive Functions in Mild Traumatic Brain Injury Patients

Neurotrauma reports, 2023-11, Vol.4 (1), p.751-760

2023

Volltextzugriff (PDF)

The Effectiveness of Dignity Therapy as Applied to End-of-Life Patients with Cancer in Taiwan: A Quasi-Experimental Study

Asian Nursing Research, 2020, 14(4), , pp.189-195

2020

Volltextzugriff (PDF)

Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease

Cancer biology & therapy, 2011-01, Vol.11 (1), p.111-121

2011

Volltextzugriff (PDF)

The impact of a multidisciplinary cardio‐oncology programme on cardiovascular outcomes in Taiwan

ESC Heart Failure, 2020-10, Vol.7 (5), p.2135-2139

2020

Volltextzugriff (PDF)

Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities

Acta Cardiologica Sinica, 2022-01, Vol.38 (1), p.039-046

2022

Volltextzugriff (PDF)

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study

Frontiers in oncology, 2021-07, Vol.11, p.671127-671127

2021

Volltextzugriff (PDF)

Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking

Oncology letters, 2019-06, Vol.17 (6), p.5740-5746

2019

Volltextzugriff (PDF)

Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells

Cancer science, 2010-09, Vol.101 (9), p.2033-2038

2010

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer

Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer

Emerging role of microRNA-21 in cancer

The association between obesity and gynecological cancer

Concurrent chemoradiotherapy in patients with non‐metastatic upper urinary tract urothelial carcinoma: Report from a single institution in Taiwan

The impact of COVID-19 on cardio-oncology care in Taiwan

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety

Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study

Dignity and Related Factors in Patients with Cancer: A Cross-Sectional Study

Correlation of Insulin-Like Growth Factor 1 With Cognitive Functions in Mild Traumatic Brain Injury Patients

The Effectiveness of Dignity Therapy as Applied to End-of-Life Patients with Cancer in Taiwan: A Quasi-Experimental Study

Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease

The impact of a multidisciplinary cardio‐oncology programme on cardiovascular outcomes in Taiwan

Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study

Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking

Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells

Suchergebnisse filtern